Literature DB >> 4762016

Lymphoblast proliferation and humoral antibody response after rubella vaccination.

M Lalla, T Vesikari, M Virolainen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4762016      PMCID： PMC1553881     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  25 in total

1.  Rubella hemagglutinin prepared in serum free suspension culture of BHK-21 cells.

Authors:  P E Halonen; J A Stewart; A D Hall
Journal:  Ann Med Exp Biol Fenn       Date:  1967

2.  Rubella: a method for rapid diagnosis of a recent infection by demonstration of the IgM antibodies.

Authors:  T Vesikari; A Vaheri
Journal:  Br Med J       Date:  1968-01-27

3.  Rubella virus and human lymphocytes in culture.

Authors:  M J Simons; M G Fitzgerald
Journal:  Lancet       Date:  1968-11-02       Impact factor: 79.321

4.  Serum IgM and IgG responses in postnatally acquired rubella.

Authors:  J M Best; J E Banatvala; D Watson
Journal:  Lancet       Date:  1969-07-12       Impact factor: 79.321

Review 5.  The atypical lymphocyte.

Authors:  T A Wood; E P Frenkel
Journal:  Am J Med       Date:  1967-06       Impact factor: 4.965

6.  Interaction between human blood platelets, viruses and antibodies. IV. Post-Rubella thrombocytopenic purpura and platelet aggregation by Rubella antigen-antibody interaction.

Authors:  G Myllylä; A Vaheri; T Vesikari; K Penttinen
Journal:  Clin Exp Immunol       Date:  1969-03       Impact factor: 4.330

7.  Rubella vaccination in adult females.

Authors:  R E Weibel; J Stokes; E B Buynak; M R Hilleman
Journal:  N Engl J Med       Date:  1969-03-27       Impact factor: 91.245

8.  The relationship of infection and DNA-synthesizing cells in human blood.

Authors:  D W Gump; F R Fekety
Journal:  J Lab Clin Med       Date:  1967-03

9.  Clinical and laboratory studies with rubella vaccines in adults.

Authors:  J A Dudgeon; W C Marshall; C S Peckham; G T Hawkins
Journal:  Br Med J       Date:  1969-02-01

10.  Lymphoid cellular responses in the blood after immunization in man.

Authors:  D Crowther; G H Fairley; R L Sewell
Journal:  J Exp Med       Date:  1969-05-01       Impact factor: 14.307
View more
  9 in total

1.  Lymphocyte responses to rubella antigen and phytohemagglutinin after administration of the RA 27/3 strain of live attenuated rubella vaccine.

Authors:  T Vesikari; E Buimovici-Klein
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

2.  Cell mediated immunity in experimental rubella infections.

Authors:  R Cappel
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

3.  Efficacy and immune response to rubella subunits vaccines.

Authors:  R Cappel; F De Cuyper
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

4.  Programmes for the prevention of rubella during pregnancy by active immunization.

Authors:  D S Freestone
Journal:  Br J Prev Soc Med       Date:  1974-11

5.  Immunologic aspects of ozena.

Authors:  P Sipilä; K Hyrynkangas
Journal:  Arch Otorhinolaryngol       Date:  1984

6.  Cell-mediated immunity in rubella assayed by cytotoxicity of supernatants from rubella virus-stimulated human lymphocyte cultures.

Authors:  T Vesikari; G Y Kanra; E Buimovici-Klein; L Z Cooper
Journal:  Clin Exp Immunol       Date:  1975-01       Impact factor: 4.330

7.  Hyperbasophilic immunoblasts in circulating blood in chronic inflammatory rheumatic and collagen diseases.

Authors:  F Delbarre; A Le Gô; A Kahan
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

8.  Cell-mediated immune response following natural rubella and rubella vaccination.

Authors:  M C Honeyman; J M Forrest; D C Dorman
Journal:  Clin Exp Immunol       Date:  1974-08       Impact factor: 4.330

9.  Cell-mediated immunity in humans during viral infection. I. Effect of rubella on dermal hypersensitivity, phytohemagglutinin response, and T lymphocyte numbers.

Authors:  C A Kauffman; J P Phair; C C Linnemann; G M Schiff
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.